Concord Biotech Ltd. (CONCORDBIO)
Market Closed
10 Aug, 10:00
XNSE XNSE Primary MSE ₹
1,419. 00
+54
+3.956%
₹
229.78B Market Cap
- P/E Ratio
35% Div Yield
360,085 Volume
- Eps
₹ 1,365
Previous Close Want to track CONCORDBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Concord Biotech Ltd. (CONCORDBIO) Statistics
Valuation metrics
Market Cap 229.78B
Enterprise value 142.69B
Trailing P/E (ttm) 52.02
Forward P/E -
PEG ratio -2.27
Price/Sales (ttm) 12.88
Price/Book (mrq) 7.08
Enterprise Value/Revenue 12.87
Enterprise Value/EBITDA 33.56
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 233.23K
Average volume (90 days) 269.64K
Price summary
52-Week low 987
52-Week high 1,801.9
Beta -
50-Day moving average 1,317.33
200-Day moving average 1,196.59
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 7.55
Trailing annual dividend yield 0.0055%
5-Year annual dividend yield -
Payout ratio 0.41
Dividend Date 9 Oct 2025
Ex-Dividend Date 3 Sep 2025
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.25%
Operating margin 0.28%
Operational effectiveness
Return on assets 0.12%
Return on equity 0.15%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 105.95
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 26.27
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 39.73
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 7.39%
Book value per share (mrq) 192.62
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
